Advanced Hearing Assessment System with Enhanced Accuracy and Personalization

Publication ID: 24-11857312_0001_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Advanced Hearing Assessment System with Enhanced Accuracy and Personalization,” Published Technical Disclosure No. 24-11857312_0001_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857312_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,312.

Summary of the Inventive Concept

An innovative hearing assessment system that leverages functional near-infrared spectroscopy (fNIRS) and advanced signal processing techniques to provide more accurate and personalized hearing assessments, addressing limitations of existing methods.

Background and Problem Solved

The original patent described a hearing assessment system using fNIRS, which, while promising, had limitations in terms of ambient noise interference, signal quality, and personalized assessment. The new inventive concept addresses these limitations by incorporating noise-cancellation modules, adaptive aural stimulation, machine learning algorithms, and advanced signal processing techniques to improve accuracy and provide personalized results.

Detailed Description of the Inventive Concept

The advanced hearing assessment system comprises a fNIRS device, a noise-cancellation module, and an advanced signal processing unit. The noise-cancellation module adaptively adjusts its noise-reduction parameters based on real-time brain activity measurements. The system dynamically adjusts the intensity of aural stimulation based on the patient's brain activity responses and incorporates machine learning algorithms to improve the reliability of the assessment results. The system also features a wearable fNIRS sensor and a mobile application, enabling real-time feedback to the patient and remote monitoring by healthcare professionals. Additionally, the system applies wavelet denoising and independent component analysis to improve the signal-to-noise ratio of the fNIRS signals, enabling more accurate detection of hearing impairments.

Novelty and Inventive Step

The new inventive concept introduces several novel features, including the adaptive noise-cancellation module, dynamic aural stimulation adjustment, and incorporation of machine learning algorithms. These advancements provide a significant improvement in accuracy and personalization, distinguishing the new concept from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the type of sensors used, the specific machine learning algorithms employed, or the integration of additional modalities, such as electroencephalography (EEG) or magnetoencephalography (MEG), to further enhance the system's accuracy and versatility.

Potential Commercial Applications and Market

The advanced hearing assessment system has significant commercial potential in the healthcare industry, particularly in audiology and otolaryngology clinics. The system's improved accuracy and personalization capabilities could lead to increased adoption and market share, with potential applications in screening, diagnosis, and monitoring of hearing impairments.

Field of Art

Medical diagnostics and neuroimaging, specifically hearing assessment technologies using functional near-infrared spectroscopy (fNIRS), requiring advanced signal processing and biomedical engineering expertise

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or neuroscientist with expertise in neuroimaging techniques, signal processing algorithms, and medical diagnostic instrumentation, holding a PhD or equivalent professional experience in biomedical engineering or neurotechnology

Obviousness Rationale

A person having ordinary skill would recognize that the PTD's variations represent predictable extensions of the source patent's core fNIRS hearing assessment methodology. The disclosed adaptive noise-cancellation, machine learning integration, and dynamic stimulation adjustment are logical incremental improvements that leverage known signal processing techniques within the established framework of the original patent. These modifications represent standard engineering problem-solving approaches to enhancing diagnostic accuracy and personalization.

Obvious Combinations & Variations

Source Patent Element
Method of delivering aural stimulation with variable parameters and processing response signals
PTD Variation
Dynamically adjusting aural stimulation intensity based on real-time brain activity responses
Obviousness Reasoning
A PHOSITA would find it obvious to implement adaptive stimulation parameters as a predictable optimization technique, using known feedback control principles to improve diagnostic precision
Source Patent Element
Signal processing techniques for removing unwanted signal elements
PTD Variation
Applying wavelet denoising and independent component analysis to improve signal-to-noise ratio
Obviousness Reasoning
These are standard signal processing techniques well-known in the art for enhancing neuroimaging data, representing a straightforward application of known denoising methodologies
Source Patent Element
Basic fNIRS hearing assessment method
PTD Variation
Incorporating machine learning algorithms to create patient-specific brain activity profiles
Obviousness Reasoning
Machine learning integration for personalized medical diagnostics is a predictable evolution in biomedical technologies, representing an obvious approach to improving diagnostic accuracy
Source Patent Element
Functional near-infrared spectroscopy measurement system
PTD Variation
Wearable fNIRS sensor with mobile application for real-time feedback and remote monitoring
Obviousness Reasoning
Miniaturization and mobile integration of medical diagnostic technologies is a known trend, representing an obvious design improvement for increased patient accessibility
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857312 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and therefore unpatentable. The published technical disclosure demonstrates that the proposed hearing assessment system modifications represent predictable combinations of known techniques, lacking the requisite non-obviousness for patent protection under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,312
TitleHearing assessment system and method
Assignee(s)THE BIONICS INSTITUTE OF AUSTRALIA